Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations

A library of novel imidazole-1,2,3-triazole hybrids were designed and synthesized based on the hybrid pharmacophore approach. Therefore, copper(I)catalyzed click reaction of thiopropargylated-imidazole 2 with several organoazides yielded two sets of imidazole-1,2,3-triazole hybrids carrying differen...

Full description

Bibliographic Details
Main Authors: Fawzia Al-blewi, Salma Akram Shaikh, Arshi Naqvi, Faizah Aljohani, Mohamed Reda Aouad, Saleh Ihmaid, Nadjet Rezki
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/3/1162
_version_ 1797407722932535296
author Fawzia Al-blewi
Salma Akram Shaikh
Arshi Naqvi
Faizah Aljohani
Mohamed Reda Aouad
Saleh Ihmaid
Nadjet Rezki
author_facet Fawzia Al-blewi
Salma Akram Shaikh
Arshi Naqvi
Faizah Aljohani
Mohamed Reda Aouad
Saleh Ihmaid
Nadjet Rezki
author_sort Fawzia Al-blewi
collection DOAJ
description A library of novel imidazole-1,2,3-triazole hybrids were designed and synthesized based on the hybrid pharmacophore approach. Therefore, copper(I)catalyzed click reaction of thiopropargylated-imidazole 2 with several organoazides yielded two sets of imidazole-1,2,3-triazole hybrids carrying different un/functionalized alkyl/aryl side chains <b>4a</b>–<b>k</b> and <b>6a</b>–<b>e</b>. After full spectroscopic characterization using different spectral techniques (IR, <sup>1</sup>H, <sup>13</sup>C NMR) and elemental analyses, the resulted adducts were screened for their anticancer activity against four cancer cell lines (Caco-2, HCT-116, HeLa, and MCF-7) by the MTT assay and showed significant activity. In-silico molecular docking study was also investigated on one of the prominent cancer target receptors, i.e., glycogen synthase kinase-3β (GSK-3β), revealing a good binding interaction with our potent compound, <b>4k</b> and was in agreement with the in vitro cytotoxic results. In addition, the ADMET profile was assessed for these novel derivatives to get an insight on their pharmacokinetic/dynamic attributes. Finally, this research design and synthesis offered click chemistry products with interesting biological motifs mainly 1,2,3 triazoles linked to phenyl imidazole as promising candidates for further investigation as anticancer drugs.
first_indexed 2024-03-09T03:46:39Z
format Article
id doaj.art-a8be48d7879944be9a01fda16855b74e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T03:46:39Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a8be48d7879944be9a01fda16855b74e2023-12-03T14:34:09ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-01-01223116210.3390/ijms22031162Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking InvestigationsFawzia Al-blewi0Salma Akram Shaikh1Arshi Naqvi2Faizah Aljohani3Mohamed Reda Aouad4Saleh Ihmaid5Nadjet Rezki6Department of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaPharmacognosy and Pharmaceutical Chemistry Department, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Munawarah 30002, Saudi ArabiaA library of novel imidazole-1,2,3-triazole hybrids were designed and synthesized based on the hybrid pharmacophore approach. Therefore, copper(I)catalyzed click reaction of thiopropargylated-imidazole 2 with several organoazides yielded two sets of imidazole-1,2,3-triazole hybrids carrying different un/functionalized alkyl/aryl side chains <b>4a</b>–<b>k</b> and <b>6a</b>–<b>e</b>. After full spectroscopic characterization using different spectral techniques (IR, <sup>1</sup>H, <sup>13</sup>C NMR) and elemental analyses, the resulted adducts were screened for their anticancer activity against four cancer cell lines (Caco-2, HCT-116, HeLa, and MCF-7) by the MTT assay and showed significant activity. In-silico molecular docking study was also investigated on one of the prominent cancer target receptors, i.e., glycogen synthase kinase-3β (GSK-3β), revealing a good binding interaction with our potent compound, <b>4k</b> and was in agreement with the in vitro cytotoxic results. In addition, the ADMET profile was assessed for these novel derivatives to get an insight on their pharmacokinetic/dynamic attributes. Finally, this research design and synthesis offered click chemistry products with interesting biological motifs mainly 1,2,3 triazoles linked to phenyl imidazole as promising candidates for further investigation as anticancer drugs.https://www.mdpi.com/1422-0067/22/3/11621,2,3-triazoleimidazoleclick synthesisanticancer activitydocking study
spellingShingle Fawzia Al-blewi
Salma Akram Shaikh
Arshi Naqvi
Faizah Aljohani
Mohamed Reda Aouad
Saleh Ihmaid
Nadjet Rezki
Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
International Journal of Molecular Sciences
1,2,3-triazole
imidazole
click synthesis
anticancer activity
docking study
title Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
title_full Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
title_fullStr Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
title_full_unstemmed Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
title_short Design and Synthesis of Novel Imidazole Derivatives Possessing Triazole Pharmacophore with Potent Anticancer Activity, and In Silico ADMET with GSK-3β Molecular Docking Investigations
title_sort design and synthesis of novel imidazole derivatives possessing triazole pharmacophore with potent anticancer activity and in silico admet with gsk 3β molecular docking investigations
topic 1,2,3-triazole
imidazole
click synthesis
anticancer activity
docking study
url https://www.mdpi.com/1422-0067/22/3/1162
work_keys_str_mv AT fawziaalblewi designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT salmaakramshaikh designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT arshinaqvi designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT faizahaljohani designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT mohamedredaaouad designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT salehihmaid designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations
AT nadjetrezki designandsynthesisofnovelimidazolederivativespossessingtriazolepharmacophorewithpotentanticanceractivityandinsilicoadmetwithgsk3bmoleculardockinginvestigations